| Application no. and date | 16196233.7 (espacenet) (Federated) (European Patent Register), 20110105 | | Patent/reg. no. and date | DK/EP 3159405, 20180912 | | Publication date | 20170426 | | Priority no. and date | US 282228 P, 20100105, US 282247 P, 20100107 | | EP pub. no. and date |
EP 3159405 20170426 | | Effective date | | | Applicant/owner | Vascular Biogenics Ltd., 8 Hasatat St.
Modiin 7178106, IL | | Applicant ref. no. | LU-PV-278347/EP-DK-DCR | | Inventor | BREITBART, Eyal, 27 Hayitzhar Street
73127 Hashmonaim, IL,
FEIGE, Erez, P.O. Box 170
50295 Hemed, IL,
COHEN, Yael, 100 Stern Street
55602 Kiryat-Ono, IL,
SHER, Naamit, 3 Paldi Street
76248 Rechovot, IL,
BANGIO, Livnat, 1 Daniel Lifshitz Street
49776 Petah-Tikva, IL | | Representative | Dennemeyer & Associates S.A, P.O. Box 700425
DE-81304 Munich, DE | | Opponent | | | IPC Class | C12N 15/00 (2006.01) | | Title | FREMGANGSMÅDER TIL ANVENDELSE AF ET SPECIFIKT ANTI-ANGIOGENT
ADENOVIRUSMIDDEL | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
